| Tag | Content |
|---|
EnhancerAtlas ID | HS091-33967 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr3:38170880-38173080 |
Target genes | | Number: 10 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr3:38171546-38171567 | AAAATAAAAATAAAAGTAACC | - | 6.49 | | Myod1 | MA0499.1 | chr3:38172293-38172306 | AGTGACAGCTGCC | - | 6.04 | | ZNF263 | MA0528.1 | chr3:38170883-38170904 | GGAGGAGGAAGAGGAGGAGAA | + | 10.59 | | ZNF263 | MA0528.1 | chr3:38170889-38170910 | GGAAGAGGAGGAGAAGGTAAG | + | 6.08 | | ZNF263 | MA0528.1 | chr3:38170886-38170907 | GGAGGAAGAGGAGGAGAAGGT | + | 7.41 | | ZNF263 | MA0528.1 | chr3:38170880-38170901 | TGGGGAGGAGGAAGAGGAGGA | + | 8.15 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_43211 | chr3:38170259-38171468 | Lung | | SE_51063 | chr3:38171486-38172890 | Sigmoid_Colon |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TGGGGAGGAG GAAGAGGAGG AGAAGGTAAG GTGAACTGGG CCCTAGCAGG ACTCCTCCAG 60
AGATAGCTGA ACACTTGGCA AGTGCTAGGA AATAGCCAGG GAGCCCTAGG AAGACCAGTG 120
GGCCTCTGGG AGTCACAGGC AGGGCACTTG GCCAGCAAGG CCCAGCCACG AGTACTGAGC 180
CCTGTCTCTA TTTCGACCCC CACCCCAGGA CAGAGCACTG CACAATAAAC ACTCCTGGGG 240
GCAGGGCTAT GCTTCCCTAT ACACTGCTAA ATCAGCCAAC TGGCAATTCC AGAGAAAAGC 300
CTTCTGCTGT CAGCCACAGA GGAGGAAACA CATCCACAAG CCAGGGCCTG CCCTCAGGGC 360
CCACAAATTC AGAAGGGAGA AGAGACAATT TGAAAGTAAC CACAGGCCGG CTGTGGTGGC 420
TCACGCCTGT AATCCCAGCA CTTTGGGAGG CCAAGGCGGG CAGATCATGA GGCTAACATG 480
GTGAAACCCC GCCTCTACTA AAAATACAAA ACATTAGCCG GGCATGGTGG CAGGCGCCAG 540
GGTGGGAGGC TGAGGCAGGA GAATGGCGTA AACCCAGGAG GCGGAACTTG CAGTGAGATG 600
AGATCGTGTC ACTGCACTCC AGCCTGGGCG ACAGAGCGAG ACTCTGTCTC AAAAACATAA 660
ATAAATAAAA TAAAAATAAA AGTAACCACA AAGCTGAGCT CAAAGGGCAT TCAGACCTGC 720
ATAGACAAGG AAGTGCTACG AGCTGAGAGG AAGGAGACGG CAGTGTAGTG TGGTCAAAAA 780
AGGGCTTTGA GGCCATGGGG GACCCTAACA CCTCAAGGGA TGATAACAGA TAACCTTGAC 840
TGAGTGCTTT TCACGTGCCC AGCACTATTC TGAATTCTTT TGAGATATTA GAGTGCTTCA 900
GTGTCAGTCA CATGACAGAC AAATACTCCA CAGTGTAAAC TGTTGCTATT ACTCCATTTA 960
TTCTTCTCAA CTTCAACAGA GCTGAGCTAG GTATCCCCAT TTTATAGATC AGGAGACTGA 1020
GGTCTAGAGA GACTGTATAA CTTATCCATG GTGACCCAGC CTGGATCCAC ATTTAGGTAG 1080
TCTGGTCCCA GAGCCCACTT CCAACTAGAG TGCCCTGTGT TAAATACTTG CTGATCAAAG 1140
TCTATGGAGA ACAGTCAGCC TGTGATGTGG GTGTCAGGCC TGGCCCAGAT CTTAATATCC 1200
TAGTACCATC ATCCTTAACC TGCTTGGGAA TCAGATACTC TCTAAGAAAC TCATAAAAGC 1260
TCCAGCCCTT CTCAAGTTAT CCATGCCACC TCTCACCCAG TAAGATAGAA GAGCATGAGA 1320
GAAATCAAAC GGCAGTGGCC TTTGCCCAGC CAAAGTCCTT GCAGAGTGGT CTTTGGCTTT 1380
ATTTACAACT GTAGACATAG GTCATTACAA CTCAGTGACA GCTGCCACAG CCCTGGGACA 1440
GGGGCCAGCA ATGCGTCCTC TCAAGAAATA CCCTAAAGAG GATGTGAAAG GCAGCGGAGG 1500
CATGTCAGAA CCCTGGGGCT GCTCACCTCC CCCAGCCTGC CAAAGACCTT ACTCCCCTGC 1560
CCTCCCAGCA CCAGATGCCC ACCCAAGCCT GGGCACCTGT GCCCTGACCT TCCCTGGAGG 1620
CACTGCCAAA TACAACTTCT GCAGCTCCAT TTGCTGCAGC CAATGATGGA GCCACAGTCT 1680
AGGTGAAGGT GACAGTGACC AAACCACCAC AGATCTAATT ATGTCCCTCA TAGCCCATAA 1740
GCAGCTGGAA GTTTCCACAC TGGTTCCAAG GTGGGGAGAC AAAGGGACAG ACAGCCTAGT 1800
AAAATGAACA AACTAGTTAT ACAGTAGGCG CTGTCCCTGG CTTTAGGGAA CCCAAACTGC 1860
AACTTCTCTC TCAGCAGCAT CATGAATCAA CAAGGGCCCC CAAAGGAAAC CCAAATGCTG 1920
GATTTTCTCA AAATGTTTTC CCACCTTTTC CAGCCTGAAA GATTTCCAAG AAAGTAAGCT 1980
TTTAGAGGCC AATTCCCCTC CCCTGCTAGT GCTGAGAGGT GTGAGTGATT CCTGAGCAGC 2040
CAGAGTTGGT AGCCACTCTT AACCTGCATT TGTGAGAACC CACTCGTGGC CAGCTGCCTA 2100
AAGGGGATGG GGGGAATCCT GAAATCATGG CCTCTGAGAA CTCAGATGAA AATTAGTTTT 2160
ATTGTCACAA GTTGGTTAAT AAGCTCCGGC AGAAAAAAAT 2200
|
